Company Filing History:
3 out of 8 
3 out of 288 
3 out of 505 
Years Active: 2021-2023
Title: The Innovative Mind of James Theiler
Introduction
James Theiler is a distinguished inventor based in Santa Fe, NM, with a notable contribution to the field of biomedical innovation. He holds three patents, primarily focused on the development of advanced HIV vaccines using innovative antigen approaches.
Latest Patents
Among his latest inventions are HIV vaccines that incorporate population episensus antigens. These vaccines utilize a carrier and an antigen determined through the EpiGraph methodology. The patents detail methods for designing and producing HIV-1 vaccines tailored to cover antigen diversity in specific geographic regions. Additionally, Theiler's patents elucidate techniques for inducing an effector memory T cell response through carefully designed amino acid sequences, which are essential for the effective treatment and prevention of HIV-1 in subjects.
Career Highlights
Throughout his career, James Theiler has made significant advancements in vaccine development while working with prominent companies such as Vir Biotechnology, Inc. and Triad National Security, LLC. His achievements are marked by a strong commitment to leveraging scientific research for real-world applications in disease treatment.
Collaborations
Theiler has collaborated with several notable professionals in the field, including Eric Bruening and Klaus Frueh. These partnerships have allowed him to enhance his research and expand the impact of his innovative approaches in HIV vaccination.
Conclusion
James Theiler's work stands as a testament to the power of innovation in the fight against HIV. His contributions are paving the way for more effective vaccines and treatment methods, showcasing the crucial role of inventors in shaping the future of healthcare.